ライフサイエンスコーパス: PLA

1 PLA generally has the lowest emissions when compared to

2 odies against phospholipase A(2) receptor 1 (PLA(2)R1) are found in 80% of patients with membranous n

3 us oocytes, but required phospholipase A(2) (PLA(2)) activity exclusively in Muller cells.

4 Recently, a phospholipase A(2) (PLA(2)) encoded by a majority of A. xylosoxidans genomes

5 Phospholipase A(2) (PLA(2)) enzyme could be acted as a unique biomarker for

6 ssay for expression of LINC00518/PRAME and a PLA score with data on the predictive values of the info

7 udy of the complex between Varespladib and a PLA(2)-like snake venom toxin (MjTX-II).

8 ing experiment of prostate cancer cells in a PLA device for advanced cell culture.

9 In this study, Chlorella is grown under a PLA which can optimally simulate the absorption spectrum

10 over that ACT has intrinsic phospholipase A (PLA) activity, and that such activity determines AC tran

11 Plant phospholipase A (PLA) catalyzes the hydrolysis of PC to release fatty acy

12 Phospholipase A2 (PLA)-specific B cells were identified using dual-color s

13 We employed the pulsed laser ablation (PLA) technique to exfoliate GQDs from multi-wall carbon

14 a community-acquired pyogenic liver abscess (PLA) patient.

15 A pyogenic liver abscess (PLA) represents a pus-filled cavity within the liver par

16 ous source of EKE is pyogenic liver abscess (PLA).

17 tatistical difference from poly lactic acid (PLA) and polycaprolactone (PCL).

18 itation, using poly (d)(,)(l)(-)lactic acid (PLA)/poly (d)(,)(l)(-)lactic-co-glycolic acid (PLGA) (75

19 Accordingly, a graphene-like polyactic acid (PLA) layer serves as the host medium, equipped with peri

20 butadiene styrene (ABS) and polylactic acid (PLA) 3D printing activities and ex situ analysis during

21 we examine foams made from polylactic acid (PLA) and micro cellulose fibrils (MCF).

22 Particles emitted from polylactic acid (PLA) appeared to be largely composed of the bulk filamen

23 e assess the suitability of polylactic acid (PLA) as a replacement material to PDMS for microfluidic

24 ertain the effectiveness of polylactic acid (PLA) based packaging solution to store red fresh meat du

25 d a 3D-printed carbon black/polylactic acid (PLA) electrochemical sensor, which had a geometry suitab

26 ide (rGO) within 3D-printed polylactic acid (PLA) electrodes and their potential applications for sen

27 mug/min), and lactide from polylactic acid (PLA) filaments (ranging from approximately 4 to approxim

28 aerosols, and wood-infused polylactic acid (PLA) filaments generated the smallest amount.

29 BS) and conductive graphene polylactic acid (PLA) filaments, respectively.

30 Polylactic acid (PLA) is one of the most commonly used biopolymers for ma

31 biobased polymer families: polylactic acid (PLA), polyhydroxybutyrate (PHB) and bioethylene-based pl

32 n all "bioplastics" made of polylactic acid (PLA).

33 lch film with coextractable polylactic acid (PLA).

34 icroplastics [biodegradable polylactic acid (PLA)], conventional high-density polyethylene (HDPE), an

35 printed from nonconductive polylactic acid (PLA, housing) and conductive polyethylene terephthalate

36 s were developed based on poly(lactic acid) (PLA) and poly(butylene adipate-co-terephthalate) (PBAT)

37 loped using nanofibers of poly(lactic acid) (PLA) and polyethylene oxide (PEO) combined with biomass

38 kaging materials based on poly(lactic acid) (PLA) due to its eco-friendly nature.

39 Poly(lactic acid) (PLA) is a biodegradable polymer prepared by the catalyze

40 terephthalate) (PET) and poly(lactic acid) (PLA) to clean H(2) fuel and a variety of organic chemica

41 res were formulated using poly(lactic acid) (PLA) to release brimonidine at a constant rate for 35 da

42 lene succinate) (PBS) and poly(lactic acid) (PLA) were melt-blended and formed into a film by hot pre

43 mparison to non-iodinated poly(lactic acid) (PLA), validated their functionality as radio-opaque mate

44 tion of nonlamellar lysophospholipids by ACT-PLA activity into the cell membrane would form, likely i

45 Regulation of ACT-PLA activity thus emerges as novel target for therapeuti

46 oreover, we show that elimination of the ACT-PLA activity abrogates ACT toxicity in macrophages, part

47 pplying a participatory learning and action (PLA) cycle focused on diabetes prevention and control.

48 ecommends participatory learning and action (PLA) in women's groups to improve maternal and newborn h

49 apamycin treatment showed markedly amplified PLA signals for IGFBP-1 and CSNK-2beta (approximately 18

50 Using click chemistry, PLA-b-PEG400-N(3) and PLA-b-PEG2000 block copolymers were bound to adenosine a

51 that microplastics manufactured of HDPE and PLA, and synthetic fibers can affect the development of

52 CTL (-22% +/- 4%; P < 0.01) in both LEU and PLA.

53 Although anti-PLA(2)R1 antibody levels are closely associated with tre

54 in of PLA(2)R1, which was recognized by anti-PLA(2)R1 antibodies in 24 (16.0%) patients.

55 In all study patients, anti-PLA(2)R1 antibodies bound both the N-terminal (CysR-FnII

56 CTLD7 strongly correlate with the total anti-PLA(2)R1 antibody level (Spearman's rho, 0.95, 0.64, and

57 The total anti-PLA(2)R1 antibody levels of patients determined detectio

58 Total anti-PLA(2)R1 antibody levels, but not the epitope-recognitio

59 disease outcome independently of total anti-PLA(2)R1 antibody levels.

60 gram to design propargyl-linked antifolates (PLAs) against trimethoprim-resistant dihydrofolate reduc

61 timized light using programmable LED arrays (PLA)s to study the effect on algae growth and bioelectri

62 Phospholipase As (PLAs) may be directly involved in the liberation of HFAs

63 e the utility of the pigmented lesion assay (PLA) for LINC00518/PRAME expression in decisions to biop

64 The pigmented lesion assay (PLA) is a noninvasive tool validated against histopathol

65 flow that combines proximity ligation assay (PLA) and digital PCR.

66 onstrate by both a proximity ligation assay (PLA) and double chromatin immunoprecipitation (ReCHIP) t

67 Proximity Ligation Assay (PLA) demonstrated that HP1a is in close proximity to DNA

68 rane isolation and proximity ligation assay (PLA) demonstrated the translocation of Hrs from the cyto

69 Proximity ligation assay (PLA) indicated proximity between IGFBP-1 and CSNK-2beta

70 NOS eliminates the proximity ligation assay (PLA) signal in endothelial cells.

71 assays and use the proximity ligation assay (PLA) to identify oligomeric beta3-subunits, not just at

72 We describe a proximity ligation assay (PLA)-based method of assessing association of DNA and RN

73 ies using in situ proximity ligation assays (PLA).

74 LA or RcLCAT-PLA, but not Arabidopsis AtLCAT-PLA, resulted in increased occupation of HFA at the sn-1

75 block-poly (lactic acid)(1800) (mPEG(2000)-b-PLA(1800)) and (mPEG(4000)-b-PLA(2200)) were used to for

76 ) (mPEG(2000)-b-PLA(1800)) and (mPEG(4000)-b-PLA(2200)) were used to formulate individual and dual dr

77 In conclusion, we have developed a mPEG-b-PLA based micellar nanoplatform that could prevent drug

78 PEG-b-PLA and PEG-b-PCL are less toxic than commonly used orga

79 tic acid) taxane prodrugs delivered by PEG-b-PLA and PEG-b-PCL nano-assemblies display heightened pla

80 tested safely and effectively by using PEG-b-PLA and PEG-b-PCL nano-assemblies, and they display supe

81 ter prodrugs have been synthesized for PEG-b-PLA and PEG-b-PCL nano-assemblies, compatibility, and no

82 ization, and a paclitaxel (PTX) loaded-PEG-b-PLA micelle (PTX-PM) is approved for cancer treatment du

83 e hypothesize that o(LA)(8)-PTX-loaded PEG-b-PLA micelles (o(LA)(8)-PTX-PM) has a lower C(max) and hi

84 In summary, PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels may safely e

85 , preclinical and clinical research on PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels that has foc

86 PEG-b-PLA micelles are a first-generation platform for the sys

87 ore stable, and may expand the role of PEG-b-PLA micelles from "solubilizer" into "nanocarrier" for P

88 However, PEG-b-PLA micelles rapidly release PTX, resulting in widesprea

89 Notably, o(LA)8-PTX and o(LA)16-PTX in PEG-b-PLA micelles resisted backbiting chain end scission, bas

90 d, o(LA)n-PTX was more compatible with PEG-b-PLA micelles than PTX, increasing drug loading from 11 t

91 Formulating paclitaxel in PEG-b-PLA micelles, as Genexol-PM(R), permits dose escalation

92 moiety (o(LA)(8)-PTX) specifically for PEG-b-PLA micelles, gaining higher loading and slower release

93 To improve delivery of PTX by PEG-b-PLA micelles, monodisperse oligo(l-lactic acid), o(LA)8

94 )-PTX is more compatible than PTX with PEG-b-PLA micelles, more stable, and may expand the role of PE

95 er weekly IV injections at 20 mg/kg as PEG-b-PLA micelles, o(LA)8-PTX induced tumor regression in A54

96 nd o(LA)n-PTX improves PTX delivery by PEG-b-PLA micelles, providing a strong justification for clini

97 e glycol)-block-poly(D,L-lactic acid) (PEG-b-PLA) and poly(ethylene glycol)-block-poly(epsilon-caprol

98 e glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles affect drug solubilization, and a paclitax

99 e glycol)-block-poly(D,L-lactic acid) (PEG-b-PLA) micelles and poly(D,L-lactic-co-glycolic acid)-bloc

100 e glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles are nanocarriers for poorly water-soluble

101 nd activity of six targeted polymeric (PEG-b-PLA) nanoparticles for use as adenosine receptor agonist

102 However, when assayed by PLA, the beta3-subunit increases the number of PLA-posit

103 ith BrU and testing their close proximity by PLA demonstrates that RNA synthesis in individual cells

104 black nanoparticles and polylactic acid (CB/PLA).

105 r complex system compared to PEG-PLL(-g-Ce6)-PLA/Dox due to the change in distance between Dox and Ce

106 Using click chemistry, PLA-b-PEG400-N(3) and PLA-b-PEG2000 block copolymers wer

107 patients with 38 ankylotic joints at Chinese PLA General Hospital from March 01, 2012 to March 01, 20

108 cases of surgically resected WTs in Chinese PLA General Hospital and Beijing Shijitan Hospital of Ca

109 y applicable system developed at the Chinese PLA General Hospital, China, using a deep convolutional

110 ogy report described the lesion as a chronic PLA.

111 (mean GHG savings up to 1.4 kg CO2e/kg corn PLA and 2.9 kg CO2e/kg switchgrass PLA).

112 es of linear PLA (<3%) in a sample of cyclic PLA that was supposedly pure according to other characte

113 cohort of 150 patients with newly diagnosed PLA(2)R1-associated membranous nephropathy, we investiga

114 This digital PLA method has femtomolar sensitivity, which enables the

115 glycol)-poly(l-lysine)] and PEG-PLL(-g-DMA)-PLA [2,3-dimethylmaleic anhydride grafted poly(ethylene

116 Extracellular PLA(2) activity was detected in the synovial fluid from

117 his work, a simple electrochemical assay for PLA(2) activity was developed based on a screen-printed

118 he incremental cost-effectiveness ratios for PLA were INT$316 per case of intermediate hyperglycaemia

119 asures of chirality at the monomer scale for PLA and PCG, and argued, on the basis of comparison with

120 Controlled release of CAR from PLA nanoparticles (NPs) could improve its antimicrobial

121 to CIT was not significantly different from PLA at week 12 (45.9% vs 37.9%; RR, 1.21; 95% CI, 0.82-1

122 tion, showed a sustained release of PAs from PLA-NPs.

123 zation of newly synthesized proteins (FUNCAT-PLA) confirmed the ability of sAPPalpha to stimulate de

124 -loaded polylactic acid-polyethylene glycol (PLA-PEG) nanoparticles with adjustable release rates wit

125 ene-based polylactic acid filament (graphene/PLA) has been 3D printed to fabricate a range of 3D disc

126 as it may help to understand how homeostatic PLAs are regulated and how degradation and biosynthesis

127 arch could address the mechanisms behind how PLA improves survival, in order to adapt this method to

128 sts showed that the presence of cellulose in PLA improved the compostability of the foams.

129 Trans-cinnamaldehyde was more compatible in PLA which exhibited plasticization that increased molecu

130 s muscle of Piemontese beef were packaged in PLA trays closed with a lid made of PLA film and for com

131 ons were the most prevalent mutation type in PLA-positive melanomas; 82% of PLA-negative lesions had

132 s and in mammalian cells; Ca(2+)-independent PLA-beta (iPLAbeta) in particular has been implicated in

133 Interestingly, PLA-specific B cells showed increased CCR5 expression af

134 omplexes were homogenously incorporated into PLA-PEG-PLA, a biodegradable thermogel copolymer, that i

135 inst several whole snake venoms and isolated PLA(2) toxins, demonstrating potent inhibitory activity.

136 epend upon its stereochemistry and isotactic PLA shows superior thermal-mechanical performances.

137 al-color staining with fluorescently labeled PLA.

138 Poly(acid lactic) (PLA) films were produced with carotenoids extracts rich

139 skin were stabilized with poly-d,l-lactide (PLA) polymer by the emulsion-evaporation method.

140 enac (DCF) in an electrospun poly-L-lactide (PLA) scaffold.

141 ar weights (Low, High) and poly(DL-lactide) (PLA) (termed PLG-L, PLG-H, and PDLA, respectively) and w

142 plied to mixtures of cyclic poly(L-lactide) (PLA) with increasing amounts of its linear topological i

143 selected diluents with a poly(d,l-lactide) (PLA), polydimethylsiloxane (PDMS), or polystyrene (PS) m

144 :cholesterol acyltransferase-like PLAs (LCAT-PLAs) in HFA biosynthesis were characterized.

145 In vitro assays revealed that LCAT-PLAs from the HFA-accumulating plant species Physaria fe

146 The LCAT-PLAs were shown to exhibit homology to LCAT and mammalia

147 ng plant species, two class III patatin-like PLA cDNAs (pPLAIIIbeta or pPLAIIIdelta) from castor or P

148 of lecithin:cholesterol acyltransferase-like PLAs (LCAT-PLAs) in HFA biosynthesis were characterized.

149 sensitive enough to detect traces of linear PLA (<3%) in a sample of cyclic PLA that was supposedly

150 ipoprotein associated phospholipase A(2) (Lp-PLA(2)) has been characterized for its interfacial activ

151 interfacial activation and inhibition for Lp-PLA(2) and provide a new concept for researchers in buil

152 will help to design better inhibitors for Lp-PLA(2).

153 However, Lp-PLA(2) is more sensitive to darapladib when bound on LDL

154 anobeads or lipoprotein particles inhibit Lp-PLA(2) possibly by blocking the access of substrates to

155 bic aggregates stimulates the activity of Lp-PLA(2) but may not be the necessary step for catalysis.

156 The inhibition of Lp-PLA(2) by darapladib is dependent on many factors such a

157 s may not accurately reflect the residual Lp-PLA(2) activity in vivo.

158 inhibitors such as darapladib binding to Lp-PLA(2) and reduces the efficacy of the drug.

159 The in vitro Lp-PLA(2) activity assays used in clinical studies may not

160 bit homology to LCAT and mammalian lysosomal PLA(2) , and to contain a conserved and functional Ser/H

161 Therefore, it is important to monitor PLA(2) activity in biological and clinical samples.

162 Moreover, PLA demonstrated colocalization between the class II epi

163 h polylactide-stabilized gold nanoparticles (PLA-AuNPs) and methylene blue (MB) was employed as the r

164 acid)/carboxyl-multiwalled carbon nanotube (PLA/ f-MWCNT) composites to be developed into MNAs and t

165 s of GPLs by some secretory (nonhomeostatic) PLAs.

166 The noninvasive PLA enables dermatologists to significantly improve biop

167 Using this new route, a series of nonracemic PLA inhibitors was prepared and shown to possess potent

168 ation type in PLA-positive melanomas; 82% of PLA-negative lesions had no mutations, and 97% of histop

169 samples (cohort 2, n = 519), in which 88% of PLA-negative samples had no mutations.

170 We find that antagonists of PLA(2) and Cl(-) channels abolish P2X7 receptor-mediated

171 In this work, a blend of PLA and polyester was studied and its volatile compositi

172 f our knowledge, the first pediatric case of PLA caused by A. defectiva.

173 n various infections, but rarely in cases of PLA.

174 cases of COVID-19 at Fifth Medical Center of PLA General Hospital from Jan 20 to Feb 23, 2020.

175 sulin complexes into the hydrophobic core of PLA-PEG-PLA thermogel-copolymer micelles.

176 tate influence the hydrolytic degradation of PLA films.

177 for the sensitive and selective detection of PLA(2) in biological or clinical samples.

178 fourth epitope region in the CTLD8 domain of PLA(2)R1, which was recognized by anti-PLA(2)R1 antibodi

179 namaldehyde modified CO functional groups of PLA and PBAT.

180 tance to better understand the hydrolysis of PLA driven by water molecules either in liquid or in vap

181 kaged in PLA trays closed with a lid made of PLA film and for comparison purposed in a conventional r

182 This work focuses on the modifications of PLA induced by water when simulating contact with semi-d

183 A, the beta3-subunit increases the number of PLA-positive signals generated by anti-(Nav1.5 alpha-sub

184 Purification in gas phase of PLA mixtures was established based on SY curves obtained

185 n and the C-terminal (CTLD7-CTLD8) region of PLA(2)R1 at study enrollment.

186 om plasma as well as culture supernatants of PLA-specific cells were measured by ELISA.

187 epitope regions in the N- and C-terminals of PLA(2)R1 at diagnosis, contradicting the hypothesis that

188 d that MCF decreased the glass transition of PLA allowing for a decrease in cell wall thickness when

189 We changed the wettability of PLA substrates and demonstrated the functionalization me

190 ther our knowledge regarding the function of PLAs from HFA-producing plant species, two class III pat

191 t the use of community mobilisation based on PLA to prevent type 2 diabetes in this rural Bangladeshi

192 We successfully cultured human cells on PLA substrates and devices, without coating.

193 When exposed to fibers or PLA microplastics, fewer seeds germinated.

194 PHB or PLA/PLGA as encapsulating material in the production of

195 Phase separation was higher in PBAT/PLA films due to less surface adhesion in PBAT networks.

196 A60/PBAT40 (PLA/PBAT) and PBAT60/PLA40 (PBAT/PLA) with incorporated trans-cinnamaldehyde using cast-e

197 erephthalate) (PBAT) blends as PLA60/PBAT40 (PLA/PBAT) and PBAT60/PLA40 (PBAT/PLA) with incorporated

198 When the PBS composition of PBS/PLA blends was changed from 40 wt% to 50 wt%, the mean p

199 NP-[CPP] is formed by PEG-PLA chains modified with a cell penetrating peptide (CPP

200 ver conventional delivery systems (e.g., PEG-PLA micelles with no co-encapsulated CaWO(4), or an orga

201 psulated radioluminescent nanoparticle ("PEG-PLA/CWO/PTX") formulation was confirmed by the MTT assay

202 In vivo study validated the efficacy of PEG-PLA/CWO/PTX-based intratumoral chemo-radio therapy in mo

203 ly(ethylene glycol)-poly(lactic acid) or PEG-PLA).

204 ethylene glycol (PEG)-polylactide (PLA) (PEG-PLA) NPs were loaded with auranofin (ARN), an antirheuma

205 mplexes into the hydrophobic core of PLA-PEG-PLA thermogel-copolymer micelles.

206 were homogenously incorporated into PLA-PEG-PLA, a biodegradable thermogel copolymer, that instantan

207 distribution (BD) study demonstrate that PEG-PLA/CWO/PTX NPs remained at the tumor sites for a long p

208 ting plant species Physaria fendleri (PfLCAT-PLA) and castor (RcLCAT-PLA) could cleave acyl chains at

209 Therefore, PfLCAT-PLA and RcLCAT-PLA may contribute to HFA turnover on PC,

210 ermore, co-expression of RcFAH12 with PfLCAT-PLA or RcLCAT-PLA, but not Arabidopsis AtLCAT-PLA, resul

211 The A-type phospholipases (PLAs) are key players in glycerophospholipid (GPL) homeo

212 to groups prescribed CIT (n = 101), placebo (PLA; n = 99), CGT with CIT (n = 99), and CGT with PLA (n

213 s hindlimb ischemia/reperfusion) or placebo (PLA) before 60/180 minutes coronary occlusion/reperfusio

214 , propionate (HP), butyrate (HB) or placebo (PLA) were rectally administered during fasting and postp

215 hrice-daily leucine (LEU; n = 8) or placebo (PLA; n = 8) supplementation (15 g/d).

216 ifestyle [ILS], metformin [MET], or placebo [PLA]), over an average of 3.2 years of follow-up.

217 howed increased frequencies of plasmablasts, PLA-specific memory B cells, and IL-10-secreting CD73(-)

218 Polylactide (PLA) is a fully biodegradable and recyclable plastic, pr

219 Polylactide (PLA) is an FDA-approved polymer derived from renewable r

220 Polylactide (PLA) is the leading bioderived polymer produced commerci

221 Conventional polyesters such as polylactide (PLA) or its copolymer, polylactide-co-glycolide (PLGA),

222 t, when other polymers, such as polylactide (PLA) or polycaprolactone (PCL), were used as the hydroph

223 Polyethylene glycol (PEG)-polylactide (PLA) (PEG-PLA) NPs were loaded with auranofin (ARN), an

224 unctionalized polystyrene (PS), polylactide (PLA), or polydimethylsiloxane (PDMS) macromonomer mediat

225 s of systematic comparison with polylactide (PLA)-based BCPs*, previously shown to exhibit chirality

226 t propylene oxide (PO) to yield polylactide (PLA) terminated by the -OCHMeCH2Cl group.

227 r method, an array of monodisperse polymers (PLA(x)-ran-DME(1-x))n bearing variable grafting densitie

228 Porous PLA film, was fabricated using calcium carbonate nanopar

229 ysis suggests that women's groups practising PLA improve key behaviours on the pathway to neonatal mo

230 Overall, women's groups practising PLA improved behaviours during and after home deliveries

231 Critically, unlike previous PLA-based BCP*s, the lack of a competing crystalline sta

232 Therefore, PfLCAT-PLA and RcLCAT-PLA may contribute to HFA turnover on PC, and represent

233 ria fendleri (PfLCAT-PLA) and castor (RcLCAT-PLA) could cleave acyl chains at both the sn-1 and sn-2

234 ression of RcFAH12 with PfLCAT-PLA or RcLCAT-PLA, but not Arabidopsis AtLCAT-PLA, resulted in increas

235 the respective plant inhibit the respective PLA, a negative feedback that prevents continuous overex

236 the drug diffusion mechanism, the resulting PLA scaffolds showed altered fibre morphology and enhanc

237 was treated to generate rGO within PLA (rGO-PLA) after treatment within NaBH(4).

238 sed on both applications, the 3D-printed rGO-PLA showed to be an excellent platform for sensing and b

239 As proofs-of-concept, the rGO-PLA electrode was applied for serotonin determination in

240 The rGO-PLA electrodes presented a notable current increase for

241 e same method can also be used for screening PLA(2) inhibitors.

242 Since PLA can be sensitive to the orientation of proteins with

243 Co-elution, competition, and in situ PLA experiments using full-length and truncated recombin

244 In situ PLA showed that the IDH1R132H epitope colocalizes with M

245 analysis and parameterization of the in situ PLA signals in over 1 million cells cultured on four ind

246 binding by pairs of antibodies using in situ PLA, compared to assays where each antibody preparation

247 ents determined detection of domain-specific PLA(2)R1 antibodies, and thereby epitope-recognition pat

248 ope-recognition patterns and domain-specific PLA(2)R1 antibody levels by western blot and ELISA.

249 developed ELISA showed that domain-specific PLA(2)R1 antibody levels targeting CysR, CTLD1, and CTLD

250 ontrol over tacticity to produce stereoblock PLA, from rac-lactide improves thermal properties but is

251 e/kg corn PLA and 2.9 kg CO2e/kg switchgrass PLA).

252 tudies described three autoantibody-targeted PLA(2)R1 epitope regions.

253 (ABS), extruded at a higher temperature than PLA, emitted vastly more particles and their composition

254 We demonstrated that PLA does not absorb small molecules, is transparent (92%

255 diagnosis, contradicting the hypothesis that PLA(2)R1 "epitope spreading" determines the prognosis of

256 urine and human macrophages and suggest that PLA(2) and Cl(-) channels mediate innate immunity downst

257 The PLA signals between Mcm10 and HP1a are specifically obse

258 als have a good corrosion resistance but the PLA-based porous materials have degradability in simulat

259 e mineralization of 95% was obtained for the PLA foam with 3 wt.% MCF when expressed as a fractional

260 showed that the optimized spectrum from the PLA gave an increase of 72% in the rETRmax value (190.5

261 The most common offender isolated from the PLA in children is Staphylococcus aureus.

262 The distribution of T6SS genes in the PLA and intestinal-colonizing K pneumoniae clinical isol

263 n this cohort was significantly lower in the PLA group compared with control (aOR 0.39, 0.24-0.65), r

264 betes and intermediate hyperglycaemia in the PLA group compared with the control group at the end of

265 The prevalence of T6SSs is higher in the PLA strains than in the intestinal-colonizing strains (3

266 After incorporating the PLA into their decision as to whether to biopsy a pigmen

267 Three-dimensional rendering of the PLA images validated that IGFBP-1 and CSNK-2beta interac

268 report the synthesis of 12 variations of the PLA-poly(ethylene glycol) (PEG) based precision-polyeste

269 nt material with mass spectra similar to the PLA monomer spectra.

270 The current was directly linear to the PLA(2) activity from 5 U/L to 200 U/L with a detection l

271 ed noninvasively and to further validate the PLA, somatic hotspot mutations in genes known to be driv

272 When the PLA(2)-containing sample was mixed with the nanoprobes,

273 n June 27, 2015, and June 28, 2018, with the PLA intervention running in 32 villages from June, 2016,

274 a true-living nature, which gives access to PLA materials of unprecedented microstructures.

275 e all showed toxic responses when exposed to PLA and ABS-emitted particles, where PLA-emitted particl

276 ever, one of the main limitations related to PLA is its reactivity with water.

277 The algal BPV performed better under PLA with a peak power output of 0.581 mW m(-2) for immob

278 By using PLA packaging combination it was possible to maintain an

279 is study, we demonstrate that both bee venom PLA(2) and murine sPLA(2)-X have adjuvant activity, lead

280 ry, an sPLA(2) found in bee venom (bee venom PLA(2)) administered with the incomplete Ag OVA leads to

281 fasting free glycerol concentrations versus PLA (P < 0.05).

282 From a practical point of view, PLA packaging is very well suited for semi-dry foods, bu

283 Participants' response to CGT with PLA vs PLA (82.5% vs 54.8%; relative risk [RR], 1.51; 95% CI, 1

284 histopathologically confirmed melanomas were PLA and/or mutation positive (cohort 1, n = 103).

285 osed to PLA and ABS-emitted particles, where PLA-emitted particles elicited higher response levels th

286 ncreased from 32.1% to 56.9% (P < .001) with PLA data.

287 n = 99), CGT with CIT (n = 99), and CGT with PLA (n = 96).

288 Participants' response to CGT with PLA vs PLA (82.5% vs 54.8%; relative risk [RR], 1.51; 95

289 mprove CGT outcome (CGT with CIT vs CGT with PLA: 83.7% vs 82.5%; RR, 1.01; 95% CI, 0.88-1.17; P = .8

290 added to treatment (CGT with CIT vs CGT with PLA: model-based adjusted mean [standard error] differen

291 ture increased after HA and HP compared with PLA (P < 0.05).

292 ds of 104 patients (120 eyes) diagnosed with PLA-related EKE between 1996 and 2015.

293 re was also a reduction in shoot height with PLA.

294 All patients with PLA(2)R1-associated membranous nephropathy recognize at

295 rs for poor visual outcomes in patients with PLA-related EKE.

296 One 3D print with PLA resulted in an aerosol mass size distribution with a

297 gmented lesions, first without and then with PLA gene expression information and were asked whether t

298 electrode was treated to generate rGO within PLA (rGO-PLA) after treatment within NaBH(4).

299 sensitivity and specificity with vs without PLA data.

300 imilar in prospectively collected real-world PLA samples (cohort 2, n = 519), in which 88% of PLA-neg